Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/39717
Title: A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2017
Citation: Ann. Oncol..2017 03;(28)3:541-546
Abstract: This study evaluated tumor response to olaratumab (an anti-PDGFRα monoclonal antibody) in previously treated patients with metastatic gastrointestinal stromal tumor (GIST) with or without PDGFRα mutations (cohorts 1 and 2, respectively).
PMID: 28426120
URI: https://hdl.handle.net/20.500.12530/39717
Rights: openAccess
Appears in Collections:Hospitales > H. U. 12 de Octubre > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:
File Description SizeFormat 
PMC5391707.pdf131.56 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.